Adjusted Operating Income: $273 million, highest Q2 in company history. Net Sales: $1.8 billion, down 2% year-over-year. Gross Margin: Increased by 230 basis points to 26%. Texture and Healthful ...

Q2 net sales grew +11% (cc1, +12% USD) with core operating income1 up +21% (cc, +20% USD) Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% ...

Consolidated Pretax Operating Income (Q4 2025): $236 million, compared to $285 million in Q4 2024. Consolidated Combined Ratio (Q4 2025): 96%, compared to 92.7% in Q4 2024. Full Year Consolidated ...

Sumitomo Chemical (TYO:4005) reported a remarkable turnaround in its second quarter of fiscal year 2025, with core operating income soaring 268.8% year-over-year despite facing revenue headwinds. The ...